Paper16622227
Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder M and 8 others. Infect Immun, 2006. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children. Papers, record 16622227. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16622227
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Protozoan | Major topic |
| Antigens, Protozoan | Major topic |
| Antimalarials | Major topic |
| Chloroquine | Major topic |
| Immunoglobulin G | Major topic |
| Malaria, Falciparum | Major topic |
| Membrane Proteins | Major topic |
| Merozoite Surface Protein 1 | Major topic |
| Plasmodium falciparum | Major topic |
| Protozoan Proteins | Major topic |
| Animals | |
| Child | |
| Child, Preschool | |
| Humans | |
| Infant | |
| Malaria Vaccines | |
| Parasitemia | |
| Retrospective Studies |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| MC_U117532067 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9647243 | A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. | J Immunol | 1998 | https://conductscience.org/library/papers/9647243 | PubMed |
| 2 | 12183594 | The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies. | Infect Immun | 2002 | https://conductscience.org/library/papers/12183594 | PubMed |
| 3 | 11160024 | Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. | Infect Immun | 2001 | https://conductscience.org/library/papers/11160024 | PubMed |
| 4 | 11567708 | Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. | Lancet | 2001 | https://conductscience.org/library/papers/11567708 | PubMed |
| 5 | 10497996 | Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. | Am J Trop Med Hyg | 1999 | https://conductscience.org/library/papers/10497996 | PubMed |
| 6 | 14695097 | Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. | Am J Trop Med Hyg | 2003 | https://conductscience.org/library/papers/14695097 | PubMed |
| 7 | 11172152 | A molecular marker for chloroquine-resistant falciparum malaria. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11172152 | PubMed |
| 8 | 3523398 | Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum. | Parasite Immunol | 1986 | https://conductscience.org/library/papers/3523398 | PubMed |
| 9 | 16206082 | Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. | J Infect Dis | 2005 | https://conductscience.org/library/papers/16206082 | PubMed |
| 10 | 9502606 | A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. | Am J Trop Med Hyg | 1998 | https://conductscience.org/library/papers/9502606 | PubMed |
| 11 | 15542195 | Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. | Vaccine | 2004 | https://conductscience.org/library/papers/15542195 | PubMed |
| 12 | 1694225 | A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. | J Exp Med | 1990 | https://conductscience.org/library/papers/1694225 | PubMed |
| 13 | 13880318 | Gamma-globulin and acquired immunity to human malaria. | Nature | 1961 | https://conductscience.org/library/papers/13880318 | PubMed |
| 14 | 11292349 | Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. | J Mol Biol | 2001 | https://conductscience.org/library/papers/11292349 | PubMed |
| 15 | 12117958 | High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. | Infect Immun | 2002 | https://conductscience.org/library/papers/12117958 | PubMed |
| 16 | 10697894 | Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. | Parassitologia | 1999 | https://conductscience.org/library/papers/10697894 | PubMed |
| 17 | 12518847 | Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. | Am J Trop Med Hyg | 2002 | https://conductscience.org/library/papers/12518847 | PubMed |
| 18 | 8627050 | Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. | J Infect Dis | 1996 | https://conductscience.org/library/papers/8627050 | PubMed |
| 19 | 3299709 | Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. | Science | 1987 | https://conductscience.org/library/papers/3299709 | PubMed |
| 20 | 15388456 | Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15388456 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33763871 | Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations. | Clin Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33763871 | PubMed |
| 28427418 | Immunity as a predictor of anti-malarial treatment failure: a systematic review. | Malar J | 2017 | https://conductscience.org/library/papers/28427418 | PubMed |
| 28289193 | Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28289193 | PubMed |
| 23285095 | Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda. | PLoS One | 2012 | https://conductscience.org/library/papers/23285095 | PubMed |
| 19500037 | Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19500037 | PubMed |
| 19250541 | AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5. | Malar J | 2009 | https://conductscience.org/library/papers/19250541 | PubMed |
| 18495848 | Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique. | Clin Vaccine Immunol | 2008 | https://conductscience.org/library/papers/18495848 | PubMed |
| 18053225 | How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions? | Malar J | 2007 | https://conductscience.org/library/papers/18053225 | PubMed |
| 18021388 | Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum. | Malar J | 2007 | https://conductscience.org/library/papers/18021388 | PubMed |
| 17223628 | Molecular epidemiology of malaria. | Clin Microbiol Rev | 2007 | https://conductscience.org/library/papers/17223628 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16622227
GET https://conductscience.org/api/papers/v1/16622227/references?page=2